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ABSTRACT

The main activation route for the stress response is the hypothalamo-pituitaryadrenal axis (HPA) and the sympatho-adrenomedullary system. The HPA axis is a
neuroendocrine feedback loop mediated by an array of tissue specific hormones,
receptors and neurotransmitters that regulate glucocorticoid (GC) release. GCs are
steroidal hormones produced by the adrenal glands and are key players in a negative
feedback loop controlling HPA activity. They influence the HPA axis through
glucocorticoid receptors in the hypothalamus and pituitary and through both
glucocorticoid (GR) and mineralcorticoid receptors (MR) that are co-localized in the
hippocampus. Repeated or chronic stress exerts a negative influence on these HPA axis
regulatory sites and contributes to potentially pathological conditions, especially during
early development. For example, chronic stress promotes increased maternal adrenal
gland secretion of glucocortiocoid, leading to abnormally high concentrations of GC in
the fetal environment. The timing and maturation of the HPA axis relative to birth is
highly species specific and is closely linked to landmarks in fetal development. In rats
this development of the HPA axis takes place in utero and continues even shortly after
birth. It is likely that the maternal endocrine environment will affect fetal development
during this critical time point and may alter the overall set point for the expression of
genes and their protein products that mediate fetal HPA axis function. Dexamethasone
(DEX) is a synthetic glucocorticoid (sGC) and is a consensus treatment in preterm
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pregnancies used to expedite fetal lung development. However it has been shown that
DEX causes long term physiological and behavioral disorders in prenatally-exposed
laboratory animals. Previous studies have also shown that it alters the MR: GR receptor
ratio in the hippocampus. Taking into consideration corticosteroid regulation of serotonin
receptors, especially 5HT1A receptors and their putative interaction with glucocorticoid
receptors in the hippocampus, we hypothesized that prenatal DEX exposure would lead
to changes in the expression and function of 5HT1A receptors in the hippocampus. We
administered DEX to rat dams during the last trimester of gestation and investigated the
changes in these receptors in the adult rat offspring. Radioligand receptor binding assays
were used to study hippocampal 5HT1A receptor binding affinity and number. Our
results demonstrate that hippocampal 5HT1A receptors are increased in the DEX animals
compared with controls by 36%, with no change in binding affinity. The efficiency of
ligand-induced receptor signal transduction via G-protein activation was also studied
using [35S]GTPγS incorporation assay. Using this technique, we showed that there was no
significant difference in the maximum ligand mediated stimulation (Emax) of 5HT1A
receptors between control and dex exposed animals. However, the intracellular signalling
efficiency of hippocampal 5HT1A receptors was diminished, since a significant increase
in EC50 values was obtained with the dex exposed group showing a value 51% higher
EC50 than controls. Taken together these data illustrate a considerable change in the
5HT1A component of the serotonergic system following prenatal DEX exposure.
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INTRODUCTION

STRESS AND HPA AXIS
Stress, originally defined by Hans Selye as a “non specific response of the body to
a demand” may also be defined as any environmental change: either internal or external
that disturbs the maintenance of homeostasis (Leonard, 2005). The stress response
contributes to the maintenance of homeostasis (Sapolsky, 2003) which includes a series
of physiological reactions such as endocrine activation and cardiovascular changes that
normally do not cause any psychopathological problems. It is only when a prolonged and
sustained stimulation exceeds the body capacity to maintain homeostasis that stress can
have psychopathological sequelae (Chrousos & Gold, 1992).
When an organism is exposed to a stressor, several mechanisms are activated to
restore homeostasis, most importantly, in the paraventricular nucleus of the
hypothalamus. When this brain region is stimulated by stress, it releases corticotrophin
releasing hormone (CRH) and its cosecretagogue arginine vasopressin (AVP) which
induce the release of adrenocorticotropic hormone (ACTH) into the circulation (Chrousos
& Gold, 1992). ACTH then stimulates adrenocortical cells in the rat adrenal glands to
secrete corticosterone (CORT) into the blood (Palkovits , 1987). Thus corticosteroids are
the main effectors of the HPA axis and their action mediated by corticosteroid receptors
which include both MR and GR (Herman et al.,1989). Using autoradiographic and
immunohistochemical techniques it has been shown that the hippocampus contains high
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concentrations of both these receptors in comparison to other brain regions which contain
only GR (Zhong & Ciaranello, 1995). The co-localization of these receptors in the
hippocampus allows this region to play a key role in the regulation of negative feedback
on HPA axis activity. This feedback system mediated by a delicate balance between MR
and GR activation in the hippocampus keeps HPA activity in check and thus acts to
mitigate psychopathological diseases.
LIMBIC MODULATION OF HPA AXIS
Evidence clearly shows that the limbic system is a central modulator of the HPA
axis (Jacobsen et al 1991 and Reul et al 1990) and that it is highly responsive to
fluctuations in circulating corticosteroids (Matthews, 2002 ; McEwen, B.S, 1991 and
Weinstock, 1997). As previously stated, corticosteroid receptors are highly expressed in
the limbic system particularly in the hippocampus (McEwen et al., 1968 and Sapolsky et
al., 1983) where GR and MR are colocalized (Van Eekelen et al.,1988 and Van Haarst
et al., 1997). Corticosterone exerts its feedback regulation of the HPA axis through GR
mediated inhibitory action at the level of the pituitary gland and the paraventricular
nucleus (PVN) in the hypothalamus. At a higher integrative level, corticosterone exerts
its effects on both hippocampal MR and GR depending on CORT concentration. Under
basal conditions, hippocampal neurons exert an inhibition of HPA axis activity via a MR
mediated mechanism. It follows that hippocampal GRs are activated by removing the
tonic influence of ligand activated MRs which results in a stimulatory influence on HPA
axis activity (De Kloet, 1991 and De Kloet et al., 1986).
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Serotonergic pathways originating in the midbrain raphe nuclei provide a
widespread innervation of corticolimbic structures such as the hippocampus, amygdala,
septum and frontal cortex (Abrams et al., 2005; Engin & Treit, 2007) and the activity in
these regions is integrated with that of the HPA axis in the control of glucocorticoid
secretion and the stress response. Interestingly, animal studies have shown that
corticosteroids can also alter several elements of serotonergic neurotransmission. For
example, removal of circulating corticosteroids by adrenlectomy results in anatomically
specified decreases in the indices of serotonin metabolism while stressful procedures,
which raise corticosteroid levels, produce corresponding increases in the turnover of
serotonin (5HT) (Curzon et.al 1972 and Van Loon, G.R et.al 1981); however,
corticosteroids may also act to directly modulate serotonergic transmission via serotonin
receptors (Watanabe et al., 1993). Further investigations confirmed the sensitivity of
5HT1A receptors to circulating corticosteroid levels (De Kloet et al.1986) and indicate
that specific hippocampal subfields are exquisitely sensitive to adrenal steroids. In
addition, electrophysiological studies have shown a suppression of 5 HT induced
hyperpolarization within hippocampal Ammon’s horn 1 (CA1) pyramidal cells after
brief application of steroids (Joel et al. 1991). These data indicate that there is a
functional coupling between glucocorticoid and serotonergic function within the
hippocampus. It is possible that the ascending serotonergic neurons originating in the
midbrain raphe nuclei and projecting to postsynaptic 5HT receptors in the hippocampus
may interact functionally at this site with glucocorticoid actions mediated by the balance
between activated MR and GR. Thus, the hippocampus represents a key anatomical
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structure involved in the central control of limbic hypothalamo pituitary adrenal (LHPA)
axis function and limbic circuitry.
In the brain 5HT is synthesized from the essential amino acid L-tryptophan
exclusively in

serotonergic neurons located within the midbrain raphe nuclei and

secretion of 5HT exerts a wide influence over many brain functions. Seven different
families of 5HT receptors with a total of 14 subtypes have been identified and six among
the major seven are G-protein coupled heterotrimeric receptors (GPCRs) with seven
transmembrane α helices (Hoyer et al., 2002). Most serotonergic receptors are located
postsynaptically, but 5HT1A and 5HT1B receptors are also located in the presynaptic
neuron and function as autoreceptors (Boess et al., 1994). 5HT receptors are coupled to
various effector systems mainly via G- proteins composed of the Gi /Go type which act
as inhibitors of adenylate cyclase (Raymond, et al., 1986). Stress activates the
serotonergic neurons projecting to the hippocampus and

amygdala through cortical

association areas and through ascending catecholaminergic neurons from the brain stem
(Feldman et al. 1998 and Koob & Heinrichs, 1999). Interestingly, stress activation of the
serotonergic system may stimulate both anxiogenic and anxiolytic pathways depending
on the type of serotonin receptors stimulated. Moreover, perturbations in serotonergic
activity have been closely linked to the pathogenesis of anxiety and other psychaitric
disorders (Totterdell, 2006; Firk & Markus, 2007; Engin & Treit, 2007). It has also been
postulated that the serotonergic innervation of the amygdala and hippocampus mediates
the anxiogenic effects of the transmitter by activating the 5HT2A receptors whereas
activation of the 5HT1A receptors, which are highly expressed in the CA1 and CA3
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regions of the hippocampus as well as in the dentate gyrus (DG) (Chalmers and Watson,
1991; Pucadyil et al., 2005; Tokugawa et al., 2007), suppresses these anxiogenic effects
(Graeff et al., 1993).

In support of this hypothesis 5HT1A knock out mice show

increased anxiety and fear, while the chronic administration of the 5HT1A partial agonist,
8-OH-DPAT, exerts anxiolytic effects both in rodents and in patients with generalised
anxiety disorder (Ramboz et al., 1998). However studies conducted specifically on the
autoreceptors of the presynaptic neuron and the postsynaptic population of 5HT1A
receptors conclude that stimulation of presynaptic 5HT1A receptors induces anxiolytic
effects through a reduction of 5HT release (Picazo et al., 1995; File et al., 1996; King et
al., 1997; Millan et.al., 1999; Romaniuk et.al., 2001) whereas the administration of the
5HT or the 5HT1A agonist 8-OH-DPAT into the amygdala

(Hodges et al.,1987;

Gonzalez et al., 1996) and the dorsal hippocampus (Romaniuk et al., 2001) produces
anxiogenic effects.
The stress response and its subsequent glucocorticoid output exert major effects
on the expression of 5HT1A and 5HT2A receptors. Moreover, the HPA axis mediates
the stress response, and its output is under tonic inhibition by adrenal steroids in the
hippocampus and elsewhere in the brain where mineralocorticoid receptors are expressed
(Lopez et al., 1998). It has been demonstrated that the density of 5HT1A receptors
decreases in response to chronic stress or the administration of glucocorticoid and
increase after adrenalectomy. In contrast, 5HT2A receptor expression is increased by
chronic stress or chronic glucocorticoid administration and decreased in response to
adrenalectomy (Watanabe et al., 1993). In general, glucocorticoid hormone increases
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tryptophan hydroxylase activity, restores the decreased 5HT that occurs after
adrenalectomy to more normal levels (Azmitia & McEwen, 1974), and regulates the
synthesis and release of corticotropin-releasing factor (CRF) (Paull & Gibbs, 1983;
Plotsky & Sawchenko, 1987; Akana et al., 1992). It has also been shown that
glucocorticoid hormones, especially CORT, can selectively down regulate 5HT1A
receptor mRNA expression in hippocampal areas, but not in the raphe nuclei (Neumaier
et al., 2000), suggesting the the 5HT1A autoreceptors are not involved in this
glucocorticoid action. Moreover, evidence suggests that stress modifies the functionality
of 5HT1A receptors. For instance, a variety of stimuli can induce desensitization of these
receptors located in the dorsal raphe nuclei (Laaris et al., 1999; Lanfumey et al.,1999),
an effect mimicked by the injection of high doses of 5HT1A agonists (Kennett et al.,
1987; Beer et al., 1990; Seth et al., 1997). Overall, these findings suggest that 5HT1A
receptors are influenced by glucocorticoid action and may mediate both glucocorticoid
and serotonergic modulation of HPA axis activity.
HPA AXIS DEVELOPMENT AND PRENATAL PROGRAMMING
Cumulative evidence supports the claim that the HPA axis is highly susceptible to
programming during development (Matthews, 2002; Meaney, 2001; Weinstock, 2001;
Welberg and Seckl, 2001; Schneider et al., 2002; Sloboda et al., 2002). In the adult there
is clear association between HPA function, glucocorticoids, and behavior, particularly in
behavioral responses to stress (De Kloet et al., 1998). As a result, a number of research
groups have investigated the influences of the perinatal environment on neonatal, juvenile
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and adult behaviors (Matthews, 2002; Meaney 2001; Weinstock, 2001; Welberg & Seckl,
2001; Schneider et al., 2002).
The timing and maturation of the HPA axis relative to birth is highly species
specific and is linked to landmarks of brain development (Dobbings & Sands, 1979).
Growth factors, transcription factors and nutrients are known to affect brain development
and steroids in particular have powerful brain programming properties (Matsumoto &
Arai, 1997). The HPA axis is shown to have the greatest plasticity during the third
trimester of gestation, a time when set points for basal expression of genes regulating the
HPA axis are programmed according to genotype. If the fetal endocrine environment is
abnormal, for example if the GC levels is in excess, genetic programming may be reset
toward HPA axis hyperactivity.
Maternal stress during gestation may lead to a variety of behavioral,
neuroendocrine, and neuroanatomical alterations in the offspring. In the absence of direct
neural connections between the developing fetus and the dam, maternal hormones have
been hypothesized to mediate the effects of prenatal stress, particularly through
alterations in the maternal HPA axis. The role of glucocorticoids as mediators of prenatal
stress effects has been investigated by administering corticosterone (or synthetic
analogues e.g DEX) to pregnant dams and results from these studies suggest that fetal
glucocorticoid exposure mediates prenatal stress and programming of the offspring
(Maccari et al., 2003; Welberg & Seckl, 2001). Results from a few well designed
human studies are concordant with decreased adaptation to novelty, altered attention and
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increased emotionality (Huizink et al., 2004). Although the range of behavioral
abnormalities is much more limited in animals than in humans, animal models allow for
control of environmental factors and hypothesis testing based on manipulation of both the
prenatal and postnatal enviroment (Weinstock, 2001). Animal models are therefore of
great value in order to identify behavioral domains or physiological systems that are
particularly vulnerable to prenatal stress, to investigate whether individual sensitivity
plays a role, and to determine which physiological mechanisms mediate the effects of
prenatal stress (Huizink et al., 2004). The adult offspring of rat dams subjected to
stressors during gestation display increased anxiety-related behaviors, e.g., suppressed
exploration of the open areas of elevated plus maze (Rimondini et al., 2003; Zimmerberg
& Blaskey, 1998) and increased defensive withdrawal (Ward et al., 2000). An important
and more noticeable feature of prenatally stressed offspring is a hyperactive HPA axis
with an elevated basal corticosterone level (Weinstock, M., 1997). However contrary to
the aforementioned finding by Weinstock, there are reports that prenatal exposure to
betamethasone decreases anxiety in developing rats which is attributed to the increase in
the expression of neuropeptide Y in the hippocampus that is anxiolytic in nature (Velisek,
2006)
Glucocorticoids have become primary candidates for programming the fetal HPA
axis in response to prenatal stress. They are essential for normal brain development and
exert a wide spectrum of organizational effects. Under normal circumstances access of
maternal endogenous glucocorticoid to the fetus is low for two reasons: (1) expression of
11β hydroxysteroid dehydrogenase in the placenta reduces glucocorticoid-action by
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(Burton & Wadell, 1999) converting cortisol and corticosterone to inactive products cortisone and 11- dehydrocorticosterone respectively and (2) corticosteroids are
substantially complexed with proteins such as corticosteroid binding globulin (CBG) that
render it incapable of penetrating the adult blood brain barrier or the feto-placental barrier
(De Kloet et al., 1998 and Owen D. 2002).
PRENATAL GLUCOCORTICOID THERAPY
Extensive study by Liggins and Howie in the early 1970’s led to the widespread
use of synthetic glucocorticoid (sGC) as a life saving treatment to prevent respiratory
distress syndrome, by enhancing fetal lung development in those pregnancy cases in
which preterm delivery is imminent (Liggins & Howie, 1972). Preterm delivery occurs in
approximately 7- 10% of all births in North America and is responsible for about 75% of
neonatal deaths (Effects of corticosteroid for fetal maturation and perinatal outcomes.,
NIH Consensus, 1995). Neonatal morbidity was also found to be very high in surviving
preterm infants and complications such as respiratory distress syndrome, intraventricular
hemorrhage and necrotizing enterocolitis are also common. An NIH consensus
conference published a statement in 1994 indicating that one-time corticosteroid
administration is safe and without side effects for prevention of respiratory distress
syndrome in prematurely born neonates. This conclusion was based on a more positive
outcome for the immediate perinatal health from numerous studies using this treatment
(MacArthur et al.,1981; Schmand et al.,1990; Smolders-de Hass et al.,1990). The trend
in clinical practice then progressed to a protocol involving repeat injections of synthetic
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corticosteroid to pregnant women at the risk for premature delivery if delivery did not
occur in 7-10 days after the initial treatment. This protocol creates an intrauterine
environment where exposure to synthetic corticosteroids is long lasting. Interestingly, in
most of these prenatal glucocorticod therapy protocols the synthetic glucocorticoid
employed is dexamethasone.
By the late 1990’s emerging evidence, particularly from animal studies, have
suggested that there may be long term consequences on early brain development
following multiple exposures to sGC (Smith et al.,

2000). These consequences of

repeated DEX administration were unexpected since it was thought that maternal
corticosteroids are unavailable to the fetal brain due to CBG and 11β hydroxysteroid
dehydrogenase (11 β HSD) activities. However it was found that CBG cannot bind DEX
nor is the latter a good substrate for 11 β HSD (Owen D, 2002). Thus it was finally
concluded that prenatal exposure of sGC increases the level of glucocorticoid in the fetal
blood. Excess GC significantly alters the fetal endocrine environment and interferes with
the programming of the CNS especially in areas such as the hippocampus which
ultimately regulate the HPA axis and incoming serotonergic projections involved in
modulating its activity.
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SPECIFIC AIMS OF THE STUDY.
This study was designed to test the hypothesis that prenatal dexamethasone
treatment alters 5HT1A receptor function and may be associated with a hyperactive HPA
axis. Due to the increase in occurrence of preterm fetal delivery dexamethasone has been
increasingly used during late gestation (G.C, Liggins; R.N, Howie, 1972). Although the
use of prenatal dexamethasone therapy has been shown to augment the fetal lung
development, newer research conducted during the late 1990’s and early 2000 showed
that prenatal glucocorticoid therapy has long term consequences for fetal brain
development (G.N, Smith et al. 2000 ; Matthews S.G, 2000) and that it alters the
hippocampal drive on HPA axis (Shoener et al. 2006; Weinstock, M., 1997). As stated
previously, studies also suggest that fetal glucocorticoid exposure is part of the
mechanism by which prenatal stress programs the offspring (Maccari, et al. 2003 &
Welberg L.A., Seckl J.R, 2001). In fact, the hyperactivity of HPA axis following prenatal
dexamethasone exposure is believed to be due to changes in negative feedback mediated
through the corticosteroid receptors especially in the MR/GR ratio. In addition, although
ADX studies and neuronal lesions have shown that circulating corticosteroids exert a
negative regulation on the serotonergic system (Curzon et.al 1972 and Van Loon, G.R
et.al 1981), activity of the serotonergic system is also mediated through the different
types of serotonin receptors in the hippocampus and higher cortical centers. 5HT1A and
5HT2A receptors by virtue of their capability to acts as anxiolytic and anxiogenic
mediators have been a focal point for research (Graeff et al. 1993; Ramboz et al.1998).
Studies show that the expression of the 5HT1A receptor is under tonic inhibition by
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adrenal steroids in the hippocampus and elsewhere in the brain where mineralocorticoid
receptors are expressed (Lopez et al. 1998) and that glucocorticoid action on serotonergic
function may be involved in limbic system dysfunction. For example, a deficiency in
brain serotonergic activity has been proposed to increase vulnerablitiy to major
depression (Asberg et al. 1986). It is possible that a diminished availability of 5-HT
precursors such as L-tryptophan, impairments in 5-HT synthesis, release or metabolism,
and changes in 5-HT receptor function could underly this affect disorder.
In summary this study will attempt to answer the following questions: 1) Does
prenatal dexamethasone treatment alter the binding affinity of 5HT1A receptors in the
hippocampus 2) Is there a change in 5T1A receptor density in this region of the brain
following the treatment 3) Does prenatal dexamethasone treatment alter intracellular
signalling from these receptors upon stimulation?
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MATERIALS AND METHODS

EXPERIMENTAL ANIMALS AND DEX TREATMENT
Pregnant female Sprague-Dawley dams were obtained on the 9th day of gestation
from Hilltop Laboratories. Since the fetal HPA axis develops only after gestation day
(GD) 12 -13, the stress due to transportation of the dams is less likely to affect the
former. All animals were maintained on standard rat chow providing 3.85kcal/g (dry
weight) and at conditions of controlled lighting (0600-1800 hours) and temperature
(23°C). These rats were given a week of acclimatization before treatment. They were
randomly divided into two groups namely the control and dex. The treatments began on
GD 14 with the dex group receiving daily injections (sc) of dexamethasone @
150µg/kg/day: Sigma St.Louis, MO) and the control group receiving vehicle (0.9% saline
+ 0.4% ethanol) until GD 19. Data from earlier studies prove that DEX treatment
@200µg/kg/day or greater resulted in significant growth retardation and lethality in
offspring. Offspring weighed at birth were distributed in such a way that each dam nursed
10 pups, which ensured that the pups were neither overfed nor underfed. The offspring
were sexed and weaned on postnatal day 21 and females were terminated. The males
were then distributed at the rate of 2/cage according to litter preserving the treatment
groups. The offspring were also fed the same standard rat chow (3.85kcal/g). At 90 days
of age the control and the dex animals were terminated. All animals were asphyxiated
with CO2 in a pre-charged chamber and terminated by guillotine. Terminations were
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staggered between the two groups to prevent variability in resting periods. Immediately
followed by each termination, the hypothalamus and the hippocampus were excised and
stored in eppendorf tubes at -80ºC. Additional trunk blood samples were collected
immediately upon termination and were centrifuged at 1300 rpm for 5 min at 4ºC. Serum
aliquots were stored at -80ºC for CORT assay using radioimmunoassay.
TISSUE GRINDING.
The hippocampus stored at -80°C was ground into fine suspension using a polytron tissue
homogenizer in 50mM Tris buffer (at 4°C, pH 7.4). The tissue homogenate from this
first round of grinding was then centrifuged using Beckman Coulter centrifuge at
18000rpm (40000 g) at 4°C for 20 minutes. The resulting tissue pellet was then subjected
to another round of grinding and centrifugation followed by a final grinding using 20mM
Tris buffer (at RT, pH7.4). During this round of grinding the volume of the buffer was
closely monitored to make the final tissue concentration to 2mg/ml (concentration used
during the radioligand receptor binding assay). A portion of the final homogenate was
used for the radioligand receptor binding assay and the other was saved at -80ºC for [35S]
GTPγS incorporation assay.

RADIOLIGAND RECEPTOR BINDING ASSAY
The radioligand receptor binding assays are typically used to measure the binding
affinity of the receptor for its ligand as well as to determine the density of receptors in the
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tissue used. This assay makes use of a radiolabelled ligand (agonist or an antagonist),
specific for the receptor in question. Incorporation of any nonspecific binding was
avoided by using a selective receptor antagonist along with the radiolabelled ligand.
In this study the 5HT1A receptor antagonist [H3] MPPF (2'-methoxyphenyl-(N2'-pyridinyl)-p-fluoro-benzamidoethyipiperazine) (Perkin Elmer, USA) (specific activity
of 78.3 Ci/mmol) was used as the radioligand. Serial two fold dilutions of the radioligand
were made using 20mM Tris buffer (at RT, pH7.4) from 10.56 nM up to 8 dilutions.
Assay tubes were also labeled from 1 to 8 in triplicates. 250µL of the ligand from each
dilution was then pipetted into each corresponding triplicate assay tubes. This was
followed by the distribution of the tissue homogenate into all assay tubes at 500µL per
tube. To make up the volume to 1 ml per tube another 250 µL of 20mM Tris buffer (at
RT, pH7.4) was added to each tube. The tubes were then incubated at 25°C in a water
bath for one hour. The same set up was followed for estimating the nonspecific binding
using

WAY-100635

(N-[2-[4-(2-Methoxyphenyl)-1-piperazinyl]

ethyl]-N-2-

pyridinylcyclohexanecarboxamide maleate salt) (Sigma, St.Loius, MO) at 4μM
concentration (in 20mM Tris) using another set of 8x3 assay tubes that received same
respective dilutions of the radioligand, except that instead of adding the final 250μL of
the 20mM Tris buffer for volume make up, 250μL of 4μM WAY-100635 was used
which was also incubated at 25°C in a water bath for one hour.
Also to another set of 8x2 scintillations vials, 500μL of the respective radioligand
dilutions were added to get the total count of radioactivity added to each assay tube.
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Cell Harvesting and Scintillation Counting
The reaction between cell membranes and the radiolabeled ligand was terminated
by rapid filtration through Whatman GF/B glass fiber filter soaked in polyethylene glycol
using a 24 tube Brandel cell harvester. The filter with the harvested radiolabelled cell
membrane was then allowed to dry for an hour. The dried filter was cut out into circles
corresponding to the number of the respective assay tubes which were then distributed
into same numbered scintillation vials and 3ml of scintillation flour was added into each
vial. Scintillation vials were left undisturbed for about 24 hours for proper integration of
the flour with the filter after which they were taken into a liquid scintillation counter for
reading the residual radioactivity in cpms.

The liquid scintillation counter was

programmed to read only 3 H channel for a preset time of 1 minute per sample. Data was
then analyzed using the non linear curve fitting program LIGAND (Munson & Rodbard,
1980).

[35 S]GTPγS INCORPORATION ASSAY
The homogenate saved after tissue grinding was used to study the intracellular
signalling from the 5HT1A receptors upon activation by a ligand (agonist). This study
made use of the fact that the 5HT1A receptors are G-protein coupled receptors.
Three fold serial dilutions of the 5HT1A receptor agonist 8-OH-DPAT(8hydroxy-2-(di-n-propylamino) tetralin) (Sigma, St.Loius, MO) were prepared in 50mM
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Tris (@RT, pH 7.4) starting at 10 μM up to 6 dilutions. The 4X GTP buffer was made by
mixing 400mM NaCl (Sigma, St.Loius. MO), 0.8mM EGTA (Sigma, St.Loius. MO) and
12mM MgSO4 (Sigma, St.Louis. MO) in 50mM Tris buffer (pH 7.4, R.T). 120mM GDP
buffer was made by dissolving GDP (Sigma, St.Loius. MO) in 4X GTP buffer. After
calculating the radioactivity using the radioactivity decay calculator a 400pM stock of the
[35 S] GTPγS (specific activity of 1250Ci/mmol) was made in 120mM GDP buffer.
Unlabeled GTPγS (40μM; Sigma, St.Loius. MO) was also prepared in 50mM Tris buffer
(Sigma, St.Loius. MO) (pH 7.4, R.T).
The assay set up consist of triplicates of 6 assay tubes, another of basal and yet
another of nonspecific. 250μL of the drug (8-OH-DPAT) from each dilution were
pipetted into the 6 triplicates of corresponding assay tubes. To the basal tubes 250μL of
50mM Tris buffer (pH 7.4, R.T) was added. To the nonspecific 250μL of the 40μM
unlabeled GTPγS was added. All the tubes received 250μL of [35 S] GTPγS and followed
by the addition of 500μL of the tissue homogenate at 1mg/mL.
Cell Harvesting and Scintillation Counting
All the tubes were incubated exactly for 45 minutes at 30°C and the reaction was
terminated as before by rapid filtration onto a Whatman GF/B glass fiber filter as before
using the cell harvester. Filter with the harvested radiolabelled cell membrane was then
allowed to dry for an hour. The dried filter was cut out into circles corresponding to the
number of the respective assay tubes which were then distributed into same numbered
scintillation vials and 3ml of scintillation flour was added into each vial. Scintillation
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vials were left undisturbed for about 24 hours for proper integration of the flour with the
filter after which they were taken into a liquid scintillation counter for reading the
residual radioactivity in cpms. The liquid scintillation counter was programmed to read
only
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S channels for a preset time of 1 minute per sample. The results obtained were

used to calculate stimulation maximum (E

max)

and EC50 values of the ligand for the

receptor, from linear regression plots with the reciprocal of ligand (8-OH-DPAT)
concentrations on the X axis and reciprocal of percentage stimulation on the Y axis.
This study was conducted in accordance with the National Institute of Health
Guide for Care and Use of Laboratory Animals, and the protocols have been approved
by the Animal Care and Use Committee of Bucknell University
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RESULTS

Body Weight and Energy Intake
Dams that had been treated with 150µg/kg DEX daily from GD14-19 had offspring with
significantly reduced birth weights (Fig.1, Table.1; 6.79 ± 0.18 g, n= 5 for dex group;
versus 8.00 ± 0.21 g, n=4 for control; P=0.004), which is in agreement with previous
studies (Keller-Wood & Dallman, 1984; Kinnunen et al., 2003; Shoener et al., 2006). In
addition prenatal DEX exposed groups also continued to show reduced body weight at
weaning (Fig 1., Table.1; 27.76 ± 0.34 g, n=5 for dex group; versus 34.32 ± 1.5 g, n=4
for control; P <0.0005), puberty (Fig. 2., Table.1; 337.7 ± 3.4 g, n=5 for dex group;
versus 374.4 ± 5.8 g, n=4 for control; P<0.0005) and on the day of sacrifice (Fig 2.,
Table.1; 521.2 ± 5.8 g, n=5 for dex group; versus 569.0 ± 10 g, n=4 for control; P
<0.0005). These results suggest a permanent metabolic disturbance in the treated animals
which was supported by the significantly reduced daily energy intake in these animals
(Fig. 3. Table.1; 184.9 ± 0.61 kcal/day, n=5 for dex group; versus 192.3 ± 0.76 kcal/day,
n=4 for control; P<0.0005)

Binding Affinity and Receptor Density of Hippocampal 5-HT1A Receptors
In order to study the binding affinity and receptor density of hippocampal 5HT1A
receptors, radio-ligand receptor binding assays were done as described in the materials
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and methods section. We found that prenatal dex exposure significantly increased the
number of 5HT1A receptors (Bmax) in the rat hippocampus by 35% (Fig.4., Table.2;
6.1379 ± 0.355 g, n=5 for dex group; versus 4.5868 ± 0.298 g, n=4 for control, P=0.002).
However these changes in receptor density occurred with no significant change in
5HT1A receptor affinity (Kd) (Fig 5). The Kd value for the dex group was 2.53 ± 0.143
nM versus 2.298 ± 0.156 nM for control group (P=0.292). A Scatchard plot of the
specific binding is given in Fig.6. This figure illustrates that the regression lines are
parallel, indicating that there is no change in receptor affinity, whereas increased
intercept on the horizontal axis indicates a large increase in Bmax of 5HT1A receptors in
treatment group (dex animals).

G protein activation of 5HT1A Receptors.
The differences in the intracellular signalling of 5HT1A receptors were measured
in terms of [35 S] GTPγS incorporation and the Emax and EC50 values were calculated. The
results showed that there is no significant difference in ligand mediated maximum
stimulation (Emax) of hippocampal 5HT1A receptors between control and dex group
(Fig.7., Table.2; 35.91 ± 2.0 % for dex group; versus 30.83 ± 1.8 % for control,
P=0.069). However the EC50 values of 5HT1A receptors in dex group was higher than in
the control by around 51% (Fig.8., Table.2; 0.2258 ± 0.02 µM for dex group; versus
0.1095 ± 0.0155 µM for control, P=0.002) indicating that the former required a higher
concentration of the ligand (8-OH-DPAT) for saturating 50% of its hippocampal 5-HT1A
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receptors compared to the control. A double reciprocal plot is given in Fig 9. This figure
illustrates that there is no change in E

max

values between control and dex animals,

whereas a higher intercept for the dex compared to control on the X-axis indicates a
larger EC50 value for dex exposed animals.
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DISCUSSION

In the present study we demonstrate, for the first time, that prenatal exposure to
dexamethasone alters the hippocampal 5HT1A receptor number and the efficiency of
ligand mediated G-protein activation in adult male rats. Earlier studies from our lab and
others show that rats exposed to excess levels of maternal and synthetic glucocorticoid in
utero experience changes in hippocampal MR and GR expression that leads to
destabilization of HPA axis regulation (Takahashi et al., 1991; Henry et al., 1994;
Shoener et al., 2006). Additional studies have also shown that HPA axis activity is
modulated by serotonergic function (Klaassen et al., 2002) .
The relationship between corticosteroids and the serotonergic system was first
reported following autoradiographic studies which identified increased 5HT1A receptor
binding in the rat hippocampal formation one week after bilateral adrenalectomy (Biegon
et al., 1985). This report emphasized the responsiveness of the 5HT1A receptor to
CORT. In addition, several investigators have reported increases in 5HT1A receptor
binding and gene expression in adrenalectomised (ADX) rats demonstrating that these
receptors are under tonic inhibition from corticosterone. Cumulatively, these studies
emphasize the relationship between the serotonergic system and corticosteroids, however,
it is important to note that these findings were in response to only postnatal alterations in
the level of coritcosteroids. To our knowledge only a few studies have investigated the
effects of prenatal glucocorticoid exposure on the serotonergic sysytem. Since
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glucocorticoids and serotonergic function interact to control hippocampal negative
feedback regulation of HPA axis activity, we investigated the effect of prenatal DEX (a
synthetic glucocorticoid) on 5HT1A function by measuring receptor number, binding
affinity and ligand-mediated receptor G- protein activation. The key findings of our
study are that: (1) prenatal DEX administration increases the total 5HT1A receptor
number in the hippocampus (2) the functionality of these receptors is reduced in
experimental animals as evidenced by the increased EC50 values compared to controls
and (3) DEX rats consistently showed an attenuated growth rate and energy intake
throughout the study. This latter finding is consistent with other reports, one of which
followed the same paradigm of in utero DEX-exposure (Shoener et al., 2006) and the
other that adopted a gestational stress model (Baker, et al., 2009). However, our data
showing increased 5HT1A binding concurrent with a reduction in ligand-mediated Gprotein activation is novel and warrants further investigation.
The 5HT1A receptors are expressed in two distinct populations in the brain: as
somatodendritic autoreceptors on serotonin containing neurons of the raphe nuclei and as
a heteroreceptor on the postsynaptic membrane of non-serotonin containing neurons in
the cerebral cortex and limbic systems. In the raphe nuclei, locally released 5HT acts on
autoreceptors to inhibit neuronal firing (Wang & Aghajanian, 1977; Celada et al., 2001)
and reduces 5HT release in all projection targets. 5HT1A heteroreceptors, which are
more concentrated in the cortex and hippocampus, are also inhibitory. For example, the
bindng of [3H]-8-OH-DPAT, a 5HT1A receptor agonist, was reduced in both frontal
cortex and hippocampus following chronic treatment with an antidepressant, a 5HT
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reuptake inhibitor, imipramine (Mizuta & Segawa, 1989), presumably due to the down
regulation of postsynaptic 5HT1A receptor population owing to the

increased

concentrations of 5HT available for binding at the synaptic cleft. This suggests that
5HT1A heteroreceptors are responsive to varying levels of 5HT release and together,
these data underscore the integrated actions of both 5HT autoreceptors and
heteroreceptors in serotonergic signalling. Recent studies (Slotkin et al., 2006) reported
an increase in 5HT1A receptor binding in the cortex in response to prenatal doses of
0.05mg Dex/kg to 0.8mg/kg from GD 17-19. Our data are in line with these results since
we found a significant increase in hippocampal 5HT1A receptor binding, although our
protocol involved a 0.15 mg DEX/kg from GD 14-19. Together these data are mutually
supportive since the functions of the 5HT1A receptor in these brain regions are
overlapping.
When considering the interactions between glucocorticoid exposure and
serotonergic function, it is important to recognize that CORT action is mediated by two
types of intracellular receptors, the mineralcorticoid receptor and glucocorticoid receptor.
While CORT binding to MR is crucial to the tonic activation and regulation of circadian
driven processes, CORT binding to GR is most influential during the circadian peak.
Many studies have shown that these receptors act together to regulate the HPA axis rather
than one of the receptors alone (De Kloet et al., 1986; Gesing, et al., 2001). Interestingly,
the MR and GR colocalization has been detected only in the hippocampus and frontal
cortex making them the most studied brain regions in relation to the HPA axis and its
negative feedback mechanisms. In addition to its MR/GR activities, CORT selectively
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down regulates 5HT1A receptor mRNA expression in hippocampal areas, but not in
dorsal raphe nulei (Neumaier et al., 2000), presumably due to a higher CORT receptor
density in post compared to presynaptic sites (Reul & De Kloet, 1985). However this
finding by Neumaier et al cannot be used to predict the changes in hippocampal 5HT1A
receptors following prenatal exposure to glucocoticoids, especially dexamethasone. This
is because the timing of brain growth spurt is critical and during this period, brain
development is very susceptible to external manipulation. Therefore, manipulation of the
fetal environment during late gestation will impact on later stages of brain and HPA
development. So findings from our study emphasize the impact of prenatal programming
of the brain in response to synthetic glucocorticoid exposure. Our study shows that
following prenatal DEX exposure there is an increase in the number of hippocampal
5HT1A receptors coupled to a decrease in their function. Thus we state that, in addition
to the earlier findings about the decrease in GR and MR receptors following prenatal
exposure to dexamethasone, there is an overall decrease in function of hippocampal
5HT1A receptors.
However, the increase in 5HT1A receptors in response to CORT found in other
studies must be clarified in the context of this receptor’s function. For example, it has
been previously shown that 5HT1A receptor knockout mice showed increased anxietylike behavior, in three paradigms: open field, EPM, and novelty suppressed feeding
(Ramboz et al., 1998; Gross et al., 2000), however, these mice could be “rescued” if
their 5HT1A receptor expression was restored during adult stage. Thus, when 5HT1A
function is lost in these knock-out mice, a propensity for anxiety-related behaviors
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ensues. It could be hypothesized that this serotonin receptor, in part, mediates
emotionality which is associated with changes in HPA axis activity. A previous study
from our lab (Shoener et al.,

2006) showed that prenatal exposure to DEX alters

hippocampal drive which resulted in HPA axis hyperactivity in DEX-exposed animals.
After considering the results from both of our studies it could be assumed that the
hyperactivity of HPA axis observed in our prenatally DEX exposed rats could be, in part,
due to a decrease in the 5HT1A receptor functions. Although the DEX exposed animals
in our study exhibit an increase in 5HT1A receptor density, the concomitant increase in
the EC50 value of these receptors suggests that the dose of agonist required to activate the
receptors and induce GTP incorporation was significantly higher. These findings support
the hypothesis that 5HT1A receptor function has been impaired by exposure to prenatal
DEX.
Although serotonin release is a key component of serotonergic function, a study
by Slotkin et al (2006) found that alterations in presynaptic serotonin level and turnover
are not the sole driving force behind the effects of DEX on 5HT1A receptors since
upregulation was seen regardless of whether serotonin levels were increased, decreased
or remain unchanged. In fact, increases in 5HT1A receptors in the face of a rise in
presynaptic serotonin release appears particularly puzzling, since ordinarily one would
expect to see compensatory downregulation of the postsynaptic receptors. This
disconnection however provides important clues as to potential mechanisms underlying
the effects of DEX on serotonergic function. For example, a similar pattern of
postsynaptic receptor upregulation concomitant with higher presynaptic activity has also
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been reported with neuroteratogens unrelated to DEX and typically reflects loss of
postreceptor-signalling capabilities (Shahak et al., 2003). In such a situation the failure of
synaptic signals to activate postsynaptic 5HT1A receptor signalling might lead to both an
increase in presynaptic 5HT release due to reduced effectiveness of 5HT1A autoreceptors
as well as an upregulation of 5HT1A heteroreceptors in an unsuccessful attempt to
compensate for the underlying deficiency. In light of these observations, the increase in
hippocampal 5HT1A receptor number in DEX animals could be an unsuccesful attempt
to compensate for less functional receptors and loss of signal transduction as indicated by
the [35S]GTPγS incorporation assay. The role of 5HT1A autoreceptors and
heteroreceptors on anxiety and depression are quite controversial. However, a
considerable body of evidence suggest that these receptors are anxiolytic. For example,
heteroreceptors appear to play an important role in effects of drugs such as SSRI, which
are used as antidepressants. In particular, experiments consisting of the selective regional
rescue of 5HT1A receptors in 5HT1A knockout mice clearly showed that postsynaptic
5HT1A heteroreceptors in hippocampus are required for the anti-immobility effect of
SSRI treatment in animals subjected to the tail suspension test (Overstreet et al., 2003): a
finding which supports the anxiolytic role of this subset population of 5HT1A receptors.
Activation of both receptor populations results in membrane hyperpolarization and
decreased neuronal excitability. For instance activation of 5HT1A autoreceptor by 5HT
will result in an inhibitory negative feedback on the 5HT producing neurons in the raphe
nuclei by decreasing the neuronal excitability . This reduction in excitability would then
result in decreased 5HT output into the synaptic cleft and a resulting decrease in 5HT
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binding and activation of postsynaptic 5HT1A receptors which would in turn reduce
their hyperpolarizing effects. Our findings are in partial accordance with this account and
in addition, recent findings show that ADX (no circulating CORT) diminishes the affinity
of 5HT1A receptors in the dorsal raphe nuclei (autoreceptors) and CORT increases the
affinity for 5HT (Bellido et al., 2004). Thus the increase in CORT in the cited study
(Bellido et al., 2004) results in decreased firing of the presynaptic serotonergic neurons
in the dorsal raphe nulceus and a consequent decrease in 5HT available for binding to the
postsynaptic receptors including 5HT1A heteroreceptors. This reduction in 5HT1A
receptor activity results in putative anxiogenesis. Our data agrees with these findings
since a significant decrease in the functionality of 5HT1A heteroreceptors was measured
following prenatal exposure to DEX.
It is likely that the prenatal exposure to DEX in our study, in part, results in a
perturbation of 5HT1A receptor function and provides the ground for anxiogenic
outcomes. This interpretation is further supported by current studies in our lab conducted
by Joseph Donohue (unpublished). He has shown that although there is no obvious
differences between control and Dex-exposed adult offspring under basal conditions, a
brief exposure to stress results in a significant increase in anxiety-like behavior in the
elevated plus maze (P < 0.03) and a significant increase in circulating CORT (P = 0.003).
A vast body of evidence suggests that actions of 5HT mediated through
the 5HT1A receptors in the dentate gyrus may stimulate the production of neurons in the
same region. In contrast to neurons in other brain regions the granule cell layer of the
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dentate gyrus enjoys an extended period of development from gestation and continuing
into adulthood, with a continual migration of granule cell precursors into the
hippocampus from the lateral ventricles (Altman & Bayer, 1990; Rickmann et al., 1987).
Moreover,

the role of hippocampal formation in learning and memory has been

recognized for decades (Squire & Zola, 1996) and many abberations in the hippocampus
have been associated with alterations in these attributes. It is possible that defects in
learning and memory exhibited by mice and rats following prenatal glucocorticoid
therapy (Emgard et al., 2007; Noorlander et al., 2007) could be further illuminated by our
findings which support the hypothesis that prenatal dexamethasone induced hippocampal
5HT1A dysfunction may result in suppression of hippocampal neurogenesis and
subsequent deficits in memory and learning.
Future Directions:
There is growing evidence that 5HT1A receptors together with 5HT2A receptors
are responsible for the regulation HPA axis. Extensive studies have shown that 5HT1A
receptor agonists have effects similar to 5HT2A receptor antagonists in a variety of
systems (Darmani et al., 1990; Meltzer & Maes, 1995). Additional evidence about the
difference in function of these two classes of 5HT receptors comes from the observation
that administration of CORT or ACTH alters the numbers of both 5HT1A and 5HT2A
receptors quite substantially in opposite directions. In the light of all these observations
from previous studies, our lab is currently preparing to explore the effects on 5HT2A
receptors in the hippocampus as well as cortical tissue following prenatal DEX exposure.
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The hippocampus is divided into two functionally different regions, the dorsal and
ventral hippocampus. Whereas the ventral part of the hippocampus is primarily
implicated in emotional processing, the dorsal part is mainly linked to learning and
memory (Bannerman, et al., 2004). Since our study did not measure the effect on 5HT1A
receptors separately on the ventral and dorsal hippocampus, it would be interesting to
investigate the effect of prenatal DEX exposure on these receptors in these individual
regions.
As mentioned earlier Bellido et al (2004) has reported an increase in 5HT1A
autoreceptors in response to corticosterone. Since neuronal firing mediated by serotonin
will depend upon the action of the entire 5HT1A receptor subfamily, comprising both
autoreceptors and heteroreceptors, the hyperactivity of HPA axis observed in a previous
study by Shoener et al (2006) cannot be explained with the changes in the heteroreceptor
population alone. A more comprehensive picture could be drawn if the effect on 5HT1A
autoreceptors could be studied following the same stress paradigm.
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Table 1. Effects on weight at birth, weaning, puberty and on the day of sacrifice
following prenatal exposure to DEX

Group

Birth
weight(g)

Weaning
weight (g)

Weight at
puberty (g)

Sacrifice
weight (g)

Energy
intake,
(kcal/day)

Control

8.003±0.21

34.32±1.5

374.4±5.8

569.0±10

192.3±0.76

Dex-exposed

6.791±0.18*

27.76±0.34* 337.7±3.4*

P =0.004

P < 0.0005

521.2±5.8* 184.9±0.61*

P < 0.0005 P < 0.0005

P < 0.0005

Values are means ± S.E. P=0.004, P<0.0005 indicate significant difference between dexamethasone
(DEX)- exposed animals compared with controls using 1-way ANOVA for weights.
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Figure.1. Difference in the average weight at birth and weaning of dex exposed and control animals.
The birth weight of dex animals was significantly lower than control by 15%; P= 0.004. The weaning
weight of dex animals was significantly lower than control by 19%; P<0.0005.
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Figure.2. Difference in the average weight at puberty and sacrifice of dex exposed and control
animals. The pubertal weight of dex animals was significantly lower than control by 10% (P<0.0005).
The terminal weight of dex animals was significantly lower than control by 8.5% (P<0.0005).
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Figure.3. Difference in the average daily energy intake of dex exposed and control animals. The
energy intake of dex animals was significantly lower than control by 3.8% (P<0.0005)
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Table 2. Values for Dissociation constant, Binding Maximum, Stimulation Maximum,
and Effective concentration50 values (EC50) for hippocampal 5HT-1A receptor in Control
and Dex-exposed animals

Group

Kd (nM)

Bmax(fmol/mg
tissue)

EC50 (μM)

4.587±0.298

Percent
Stimulation
Max (Emax)
30.83±1.8

Control

2.298±0.156

Dex-exposed

2.531±0.143

6.138±0.355*

35.91±2.0

0.226±0.02*

P = 0.292

P = 0.002

P = 0.069

P =0.002

0.119±0.0155

Using the radioligand receptor assay, no significant differences were found in the binding affinity, Kd,
(P=0.292), whereas a significant increase in binding maximum, Bmax, was observed in the Dexexposed animals (P= 0.002). In addition, no significant difference in maximum stimulation (Emax) of
5HT1A receptor and GTPγS incorporation was detected (P=0.069). However, the effective
concentration of 5HT1A receptor agonist required for maximal stimulation was almost two-fold
higher in the Dex-exposed group (P= 0.002) Values are mean ± S.E.M.
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Figure.4. Difference in the Bmax values of control and dex exposed animals. Increased Bmax in dex
exposed animals indicate an increase in 5HT1A receptor density. Dex animals showed a receptor
density 35% higher than the control animals; P=0.002.
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Figure.5. This graph illustrates the values for the dissociation constant (Kd) which reflect the binding
affinity of the 5HT1A receptor for its ligand ([H3] MPPF). No significant difference in the affinity was
found following prenatal dexamethasone exposure; P=0.292.
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Figure 6. Scatchard analysis of [3 H] MPPF binding to rat hippocampal 5HT-1A receptors in Control
and Dex animals. Each regression line is based on one pair of representative animals.
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Figure.7. This graph shows the values of Stimulation max (Emax) which is a measure of the
maximum stimulation of [35 S] GTPγS incorporation assay following ligand (8-OH-DPAT) mediated
activation of 5HT1A receptor. No significant difference in the maximum stimulation was found owing
to prenatal dexamethasone exposure; P=0.069.
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Figure.8. Effects of prenatal exposure of dexamethasone on the EC50 value of 5HT1A receptor. The
EC50 values were determined by measuring the extent of incorporation of GTPγS following ligand (8OH-DPAT)-mediated stimulation of the 5HT1A receptor). The dex animals showed a 51% increased
EC50 value compared to controls; P=0.002.
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Figure.9. Double reciprocal plots illustrate stimulation of the 5HT1A receptor at increasing agonist
concentrations, 8-OH-DPAT, between dex exposed and control group. Each regression line is from
one representative animal.

